Transformative Oral Medicines for Severe RNA-Mediated Diseases
Small molecules, big difference
Expansion Therapeutics is pioneering tranformative oral treatments for three major neurological diseases: Myotonic Dystrophy, ALS and Alzheimer's.
450 Million People Worldwide
Neurological diseases affect
The RNA World of SMiRNA™
Expansion Therapeutics scientific founder Matthew Disney, PhD describes breakthrough discoveries in allowing small molecules to interact with RNA (SMiRNA™)
The Journey Starts Here
Your life has been impacted by one of the debilitating neurological diseases and already know plenty by experience and by a relentless pursuit for answers. Or your condition is a recent onset of disease and you don't know where to begin. We believe it's our job to join you in your quest by participating with our shared community. Listening in on the critical conversations taking place is as important as the research we are conducting. Together we can be relevant and effective on this journey.
Neurological disease FAQs
In common: Stories of people like you
Connect with a community
Join a Conversation
Nerological disease - a day in the life; Coping with your condition
Helping someone with ALS
Insights & More